Greg Pyszczymuka

Insider Reports History

Location
Englewood, CO
Signature
/s/ Matthew J. D'Onofrio, Attorney-in-fact for Greg Pyszczymuka
Transaction view
Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Holdings reported by Greg Pyszczymuka:

Form 4 holding Chief Commercial Officer

AYTU BIOPHARMA, INC

Security class
Restricted Stock Units
Shares / value
0
Estimated value
$0
Report date
31 Mar 2025
Price
$1.87
Ownership
Direct
Underlying class
Common Shares
Underlying amount
Form 4 holding Chief Commercial Officer

AYTU BIOPHARMA, INC

Security class
Employee Stock Option (Right to Buy)
Shares / value
7,000
Estimated value
Report date
06 Nov 2024
Price
Ownership
Direct
Underlying class
Common Shares
Underlying amount
Form 4 holding Director

Evoke Pharma Inc

Security class
No securities are beneficially owned.
Shares / value
0
Estimated value
Report date
20 Feb 2025
Price
Ownership
Direct
Form 4 holding Director

Evoke Pharma Inc

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
17 Dec 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Greg Pyszczymuka

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .